ORXOY Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 birž. 2024 @ 16:35):
No signals from the correlation tool

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom...

Stats
Dzisiejszy wolumen	200
Średni wolumen	154
Kapitalizacja rynkowa	74.07M
EPS	$-0.260 ( Q1 \| 2024-03-31 )
Następna data zysków	( $0 ) 2024-07-17
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.75 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

ACRDF 0.00%

ACRHF 0.00%

APNHY 0.00%

AVTBF 0.63%

AYRWF -14.89%

BBBT 0.00%

BLMS -9.09%

CBDHF 0.00%

CBGL 0.00%

CCHWF -21.71%

CENBF 0.00%

CHALF -99.00%

CNTTQ 0.00%

CRLBF -11.73%

CRYM -1.48%

DVAXW 9 900.00%

DVLP 0.00%

EAPH 12.03%

EDXC 55.17%

EMHTF 0.00%

ESALF -2.11%

ESALY 12.50%

ETST 11.90%

GDNSF -3.00%

GLASF 0.00%

GNHAY -15.36%

GRAMF 9 900.00%

HCANF 0.00%

HKMPY 0.00%

HLUYY 0.00%

HYEX -1.11%

HYPMY 0.00%

IPSEY 1.06%

ITHUF -18.67%

JUSHF 20.00%

KGKG 0.00%

LOWLF 0.00%

LVRLF 0.00%

MILC -1.14%

MKKGY -66.67%

NLBS 0.00%

NPHC 0.00%

NPPNY 0.00%

NUNZ 7.50%

ORXOY 2.13%

PLNHF 0.00%

PZOO -26.83%

RLBD 1.82%

RWBYF 0.21%

SGIOY 0.00%

TAIPY -12.10%

TCNNF 0.00%

TEVJF 0.00%

TLGTQ -11.79%

TRSSF -7.41%

UNRV -2.59%

VEXTF -13.10%

VLNCD 0.00%

VRNOF 0.00%

Korelacja (AI algo v.1.1b): Paired value (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Orexo AB (publ) Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Orexo AB (publ) Finanse

Annual	2023
Przychody:	$638.80M
Zysk brutto:	$472.80M (74.01 %)
EPS:	$-3.73

FY	2023
Przychody:	$638.80M
Zysk brutto:	$472.80M (74.01 %)
EPS:	$-3.73

FY	2022
Przychody:	$624.30M
Zysk brutto:	$521.70M (83.57 %)
EPS:	$-5.17

FY	2021
Przychody:	$565.00M
Zysk brutto:	$486.10M (86.04 %)
EPS:	$-2.13

Financial Reports:

No articles found.

Orexo AB (publ) Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Orexo AB (publ)

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; OX640, a medication for allergic reactions; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.